Ubs Group Ag Lantheus Holdings, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 7,000 shares of LNTH stock, worth $625,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,000

Previous 7,000 -0.0%

Holding current value

$625,030

Previous $562,000 36.65%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$77.7 - $123.62 $2.45 Million - $3.9 Million	31,578 Added 101.36%	62,733 $6.88 Million
Q2 2024 Aug 13, 2024	SELL	$58.87 - $83.05 $3.62 Million - $5.11 Million	-61,529 Reduced 66.39%	31,155 $2.5 Million
Q1 2024 May 13, 2024	BUY	$51.07 - $68.26 $2.07 Million - $2.76 Million	40,486 Added 77.56%	92,684 $5.77 Million
Q4 2023 Feb 09, 2024	BUY	$55.6 - $77.89 $915,787 - $1.28 Million	16,471 Added 46.1%	52,198 $3.24 Million
Q3 2023 Nov 09, 2023	SELL	$60.27 - $90.75 $1.75 Million - $2.63 Million	-29,030 Reduced 44.83%	35,727 $2.48 Million
Q2 2023 Aug 11, 2023	BUY	$82.41 - $99.65 $990,650 - $1.2 Million	12,021 Added 22.79%	64,757 $5.43 Million
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $1.97 Million - $3.42 Million	41,277 Added 360.21%	52,736 $4.35 Million
Q4 2022 Feb 08, 2023	SELL	$48.76 - $77.67 $3.28 Million - $5.22 Million	-67,181 Reduced 85.43%	11,459 $583,000
Q3 2022 Nov 10, 2022	SELL	$61.42 - $86.29 $424,289 - $596,091	-6,908 Reduced 8.07%	78,640 $5.53 Million
Q2 2022 Aug 10, 2022	BUY	$55.54 - $72.65 $699,193 - $914,590	12,589 Added 17.25%	85,548 $5.65 Million
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $660,148 - $1.54 Million	-27,189 Reduced 27.15%	72,959 $4.04 Million
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $1.39 Million - $1.88 Million	61,884 Added 161.73%	100,148 $2.89 Million
Q3 2021 Nov 15, 2021	SELL	$24.23 - $28.59 $852,120 - $1.01 Million	-35,168 Reduced 47.89%	38,264 $982,000
Q2 2021 Aug 13, 2021	BUY	$19.51 - $27.64 $841,290 - $1.19 Million	43,121 Added 142.26%	73,432 $2.03 Million
Q1 2021 May 12, 2021	SELL	$13.77 - $21.66 $219,232 - $344,848	-15,921 Reduced 34.44%	30,311 $648,000
Q4 2020 Feb 11, 2021	BUY	$10.75 - $14.91 $240,552 - $333,641	22,377 Added 93.8%	46,232 $624,000
Q3 2020 Nov 12, 2020	SELL	$11.98 - $16.34 $128,425 - $175,164	-10,720 Reduced 31.01%	23,855 $302,000
Q2 2020 Jul 31, 2020	BUY	$10.34 - $15.51 $90,960 - $136,441	8,797 Added 34.13%	34,575 $494,000
Q1 2020 May 01, 2020	SELL	$9.11 - $20.05 $244,986 - $539,184	-26,892 Reduced 51.06%	25,778 $329,000
Q4 2019 Feb 14, 2020	BUY	$18.47 - $24.03 $424,957 - $552,882	23,008 Added 77.57%	52,670 $1.08 Million
Q3 2019 Nov 14, 2019	BUY	$21.01 - $28.94 $85,132 - $117,264	4,052 Added 15.82%	29,662 $743,000
Q2 2019 Aug 14, 2019	BUY	$23.33 - $28.3 $413,197 - $501,221	17,711 Added 224.22%	25,610 $725,000
Q1 2019 May 14, 2019	SELL	$14.93 - $25.1 $96,238 - $161,794	-6,446 Reduced 44.94%	7,899 $193,000
Q4 2018 Feb 14, 2019	BUY	$12.68 - $19.01 $23,293 - $34,921	1,837 Added 14.69%	14,345 $225,000
Q3 2018 Nov 14, 2018	BUY	$13.1 - $16.35 $163,540 - $204,113	12,484 Added 52016.67%	12,508 $187,000
Q2 2018 Aug 14, 2018	SELL	$13.65 - $18.7 $20,475 - $28,050	-1,500 Reduced 98.43%	24 $0
Q1 2018 May 15, 2018	SELL	$14.85 - $24.3 $36,367 - $59,510	-2,449 Reduced 61.64%	1,524 $24,000
Q4 2017 Feb 14, 2018	SELL	$17.4 - $23.4 $41,151 - $55,341	-2,365 Reduced 37.31%	3,973 $81,000
Q3 2017 Nov 14, 2017	BUY	$15.5 - $19.15 $78,383 - $96,841	5,057 Added 394.77%	6,338 $113,000
Q2 2017 Aug 14, 2017	BUY	N/A	492 Added 62.36%	1,281 $22,000
Q1 2017 Nov 14, 2017	BUY	N/A	789	789 $10,000

Others Institutions Holding LNTH

# of Institutions

540

Shares Held

68M

Call Options Held

679K

Put Options Held

423K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account